Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Enrich Therapeutics
company
About
Enrich Therapeutics is a biotechnology startup.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology
- Founded date
- Jul 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Enrich Therapeutics is a biotechnology startup focused on the development of novel single-cell isolation platform along with the critical life science applications.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Enrich Therapeutics has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jun 3, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 3, 2019 | Grant | — | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Enrich Therapeutics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
